Ekaterina Pavlova

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

The androgen receptor depends on ligand‐binding domain dimerization for transcriptional activation

Sarah El Kharraz, Vanessa Dubois, Martin E. van Royen et al. · EMBO Reports · 2021 · 48 citations · Full text

Androgen Receptor, Transcriptional Regulation, Transcriptional Activation +14

Tumor Suppressor PTEN Regulates Negatively Sertoli Cell Proliferation, Testis Size, and Sperm Production In Vivo

Yasmine Neirijnck, Françoise Kühne, Chloé Mayère et al. · Endocrinology · 2018 · 31 citations · Full text

Spermatogenesis, Cell Proliferation, Reproductive Biology +22

Losartan suppresses the kainate-induced changes of angiotensin AT 1 receptor expression in a model of comorbid hypertension and epilepsy

Dimitrinka Atanasova, Jana Tchekalarova, Natasha Ivanova et al. · Life Sciences · 2017 · 20 citations

Molecular Pharmacology, Hypertension, Sodium Homeostasis +10